US Patent 9074211 Inhibition of MAP4K4 through RNAI
Patent 9074211 was granted and assigned to Rxi Pharmaceuticals Corporation on July, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9074211 Inhibition of MAP4K4 through RNAI
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.